{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:29:53Z","timestamp":1784834993002,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR002541"],"award-info":[{"award-number":["UL1 TR002541"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","americanjournalofsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.amjsurg.2024.115893","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:50:28Z","timestamp":1723164628000},"page":"115893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Axillary de-escalation after neoadjuvant chemotherapy for advanced lymph node involvement in breast cancer"],"prefix":"10.1016","volume":"236","author":[{"given":"Kathryn","family":"Capasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Roldan-Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8316-9415","authenticated-orcid":false,"given":"Rene","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Borgonovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger B.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.amjsurg.2024.115893_bib1","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.amjsurg.2024.115893_bib2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.22540","article-title":"Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases","volume":"109","author":"Shen","year":"2007","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.amjsurg.2024.115893_bib3","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLNBD) plus axillary lymph node dissection compared with SLNBD alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2024.115893_bib4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ijrobp.2007.07.2376","article-title":"The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone","volume":"70","author":"Deutsch","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.115893_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115893_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/bjc.1992.230","article-title":"Assessment of morbidity from complete axillary dissection","volume":"66","author":"Ivens","year":"1992","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.amjsurg.2024.115893_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjsurg.2013.02.001","article-title":"Routine completion axillary lymph node dissection for positive sentinel nodes in patients undergoing mastectomy is not associated with improved local control","volume":"205","author":"Crawford","year":"2013","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.115893_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.amjsurg.2024.115893_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.115893_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-020-05970-2","article-title":"Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?","volume":"185","author":"Garcia-Tejedor","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.amjsurg.2024.115893_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103671","article-title":"Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathologic complete response after neoadjuvant therapy: is it necessary?","volume":"73","author":"Guo","year":"2024","journal-title":"Breast"},{"issue":"14","key":"10.1016\/j.amjsurg.2024.115893_bib12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.amjsurg.2024.115893_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.115893_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.115893_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA A Cancer J Clin"},{"issue":"10","key":"10.1016\/j.amjsurg.2024.115893_bib16","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1245\/s10434-017-5958-4","article-title":"Use of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American society of breast Surgeons members","volume":"24","author":"Caudle","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.amjsurg.2024.115893_bib17","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1245\/s10434-018-6637-9","article-title":"Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy","volume":"25","author":"Nguyen","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.amjsurg.2024.115893_bib18","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1245\/s10434-020-08900-0","article-title":"Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer","volume":"27","author":"Piltin","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2024.115893_bib20","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1245\/s10434-021-09897-w","article-title":"Factors associated with nodal pathologic complete response among breast cancer patients treated with neoadjuvant chemotherapy: results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (alliance)","volume":"28","author":"Weiss","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2024.115893_bib21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1245\/s10434-018-6345-5","article-title":"A\u00a0predictive model for axillary node pathologic complete response after neoadjuvant chemotherapy for breast cancer","volume":"25","author":"Kantor","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.amjsurg.2024.115893_bib22","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1245\/s10434-021-10195-8","article-title":"Association of tumor molecular subtype and stage with breast and axillary pathologic complete response after neoadjuvant chemotherapy for breast cancer","volume":"28","author":"Myers","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.115893_bib23","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1245\/s10434-022-11367-w","article-title":"The effect of age on outcomes after neoadjuvant chemotherapy for breast cancer","volume":"29","author":"Verdial","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.115893_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10549-015-3479-z","article-title":"Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials","volume":"152","author":"Loibl","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.115893_bib25","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1245\/s10434-021-10830-4","article-title":"Is axillary radiation not inferior to axillary dissection for sentinel lymph node-positive breast cancer after neoadjuvant chemotherapy?","volume":"29","author":"Khan","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.115893_bib26","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","article-title":"NCCN Guidelines\u00ae insights: breast cancer, version 4.2023","volume":"21","author":"Gradishar","year":"2023","journal-title":"J\u00a0Natl Compr Cancer Netw"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961024004458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961024004458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T18:44:33Z","timestamp":1726080273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961024004458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":25,"alternative-id":["S0002961024004458"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2024.115893","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axillary de-escalation after neoadjuvant chemotherapy for advanced lymph node involvement in breast cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2024.115893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115893"}}